These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32764096)

  • 1. Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs.
    Dvorak Z; Klapholz M; Burris TP; Willing BP; Gioiello A; Pellicciari R; Galli F; March J; O'Keefe SJ; Sartor RB; Kim CH; Levy M; Mani S
    Mol Pharmacol; 2020 Oct; 98(4):343-349. PubMed ID: 32764096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Mimicry: Promiscuous Receptors PXR and AhR, and Microbial Metabolite Interactions in the Intestine.
    Dvořák Z; Sokol H; Mani S
    Trends Pharmacol Sci; 2020 Dec; 41(12):900-908. PubMed ID: 33097284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human microbial metabolite mimicry as a strategy to expand the chemical space of potential drugs.
    Li H; Ranhotra HS; Mani S; Dvořák Z; Sokol H; Müller R
    Drug Discov Today; 2020 Sep; 25(9):1575-1579. PubMed ID: 32562605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial Metabolites as Ligands to Xenobiotic Receptors: Chemical Mimicry as Potential Drugs of the Future.
    Dvořák Z; Li H; Mani S
    Drug Metab Dispos; 2023 Feb; 51(2):219-227. PubMed ID: 36184080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer Agents.
    Yu B; Zheng YC; Shi XJ; Qi PP; Liu HM
    Anticancer Agents Med Chem; 2016; 16(10):1315-24. PubMed ID: 26522954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations of the chemical biology of microbial natural products provide an effective drug discovery strategy.
    Choi H; Oh DC
    Arch Pharm Res; 2015 Sep; 38(9):1591-605. PubMed ID: 26231248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Bacterial Genomes for Natural Product Discovery.
    Kalkreuter E; Pan G; Cepeda AJ; Shen B
    Trends Pharmacol Sci; 2020 Jan; 41(1):13-26. PubMed ID: 31822352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective approaches to discover new microbial metabolites in a large strain library.
    Zdouc MM; Iorio M; Vind K; Simone M; Serina S; Brunati C; Monciardini P; Tocchetti A; Zarazúa GS; Crüsemann M; Maffioli SI; Sosio M; Donadio S
    J Ind Microbiol Biotechnol; 2021 Jun; 48(3-4):. PubMed ID: 33599744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospecting for new bacterial metabolites: a glossary of approaches for inducing, activating and upregulating the biosynthesis of bacterial cryptic or silent natural products.
    Zarins-Tutt JS; Barberi TT; Gao H; Mearns-Spragg A; Zhang L; Newman DJ; Goss RJ
    Nat Prod Rep; 2016 Jan; 33(1):54-72. PubMed ID: 26538321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirooxindoles as Potential Pharmacophores.
    Panda SS; Jones RA; Bachawala P; Mohapatra PP
    Mini Rev Med Chem; 2017; 17(16):1515-1536. PubMed ID: 29056096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the pregnane X receptor using microbial metabolite mimicry.
    Dvořák Z; Kopp F; Costello CM; Kemp JS; Li H; Vrzalová A; Štěpánková M; Bartoňková I; Jiskrová E; Poulíková K; Vyhlídalová B; Nordstroem LU; Karunaratne CV; Ranhotra HS; Mun KS; Naren AP; Murray IA; Perdew GH; Brtko J; Toporova L; Schön A; Wallace BD; Walton WG; Redinbo MR; Sun K; Beck A; Kortagere S; Neary MC; Chandran A; Vishveshwara S; Cavalluzzi MM; Lentini G; Cui JY; Gu H; March JC; Chatterjee S; Matson A; Wright D; Flannigan KL; Hirota SA; Sartor RB; Mani S
    EMBO Mol Med; 2020 Apr; 12(4):e11621. PubMed ID: 32153125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products.
    Muchiri RN; van Breemen RB
    J Mass Spectrom; 2021; 56(5):e4647. PubMed ID: 32955158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From nature to drug discovery: the indole scaffold as a 'privileged structure'.
    de Sá Alves FR; Barreiro EJ; Fraga CA
    Mini Rev Med Chem; 2009 Jun; 9(7):782-93. PubMed ID: 19519503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to diversify natural products for drug discovery.
    Li G; Lou HX
    Med Res Rev; 2018 Jul; 38(4):1255-1294. PubMed ID: 29064108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research Tales from the Clardy Laboratory: Function-Driven Natural Product Discovery.
    Fukuda TTH; Cassilly CD; Gerdt JP; Henke MT; Helfrich EJN; Mevers E
    J Nat Prod; 2020 Mar; 83(3):744-755. PubMed ID: 32105475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unearthing fungal chemodiversity and prospects for drug discovery.
    Greco C; Keller NP; Rokas A
    Curr Opin Microbiol; 2019 Oct; 51():22-29. PubMed ID: 31071615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural product discovery: past, present, and future.
    Katz L; Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):155-76. PubMed ID: 26739136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of the Pharmacophore Concept in Natural Product inspired Drug Design.
    Seidel T; Wieder O; Garon A; Langer T
    Mol Inform; 2020 Nov; 39(11):e2000059. PubMed ID: 32578959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary metabolomics: the impact of mass spectrometry-based approaches on the discovery and characterization of microbial natural products.
    Krug D; Müller R
    Nat Prod Rep; 2014 Jun; 31(6):768-83. PubMed ID: 24763662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The re-emerging role of microbial natural products in antibiotic discovery.
    Genilloud O
    Antonie Van Leeuwenhoek; 2014 Jul; 106(1):173-88. PubMed ID: 24923558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.